Sale

MENA Ethosuximide Market

MENA Ethosuximide Market Share, Size, Trends, Analysis: By Product: Capsule, Tablet, Syrup, Others; By Procurement: Annual Procurement (Government Agencies, Public Hospitals), Private Procurement (Drug Stores, Private Hospitals); Regional Analysis; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032

MENA Ethosuximide Market Outlook

The MENA ethosuximide market size is expected to grow at a CAGR of 3.30% between 2024 and 2032. The market is being driven by the increasing prevalence of epilepsy and growing healthcare infrastructure and expenditure.

 

mena ethosuximide market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Key Trends in the Market

Ethosuximide is an anticonvulsant drug which is used to regulate absence (petit mal) seizures in epileptic patients. The compound is obtained from succinic acid and operates by reducing instances of abnormal electrical activity in the patient’s brain. In absence seizures, the patient experiences a short loss of awareness during which there is lack of response but may continue to blink eyes or stare. 

 

  • The rapid growth of the healthcare sector across the emerging economies of the Middle East North Africa (MENA) region is driving the MENA ethosuximide market. Growing efforts by the governments in the region aimed towards reducing economic vulnerability are heightening the healthcare expenditure.
  • The increasing prevalence of absence seizures, particularly among children between the ages of 2 years and 12 years, is further escalating the demand for ethosuximide across the healthcare units.
  • The surging applications of smart and modern technologies and penetration of internet of things (IoT) and artificial intelligence, are improving the diagnostics and treatment infrastructure. Hence, advancements in neuroscience-related facilities across the region are expected to propel the usage of ethosuximide.
  • The growing research and development activities aimed towards improving the quality of medication, reducing the injuries associated with epileptic seizures, and developing minimally invasive diagnostic and treatment procedures, are likely to provide impetus to the MENA ethosuximide market in the forecast period.

 

Market Analysis

 

mena ethosuximide market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on product, the market is segmented into capsule, tablet, and syrup, among others. On the basis of procurement, the market is classified into annual procurement (government agencies, public hospitals) and private procurement (drug stores, private hospitals). By country, the market for ethosuximide in MENA is divided into Saudi Arabia, United Arab Emirates, Iran, Egypt, Morocco, Qatar, Kuwait, and Oman, among others.  

 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the MENA ethosuximide market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.

 

  • Pfizer Ltd
  • Essential Pharma Ltd
  • Qatar Pharmaceuticals Industries
  • Delta Pharma
  • Others

 

Market Share by Product

The capsule segment, based on product, accounts for a healthy share of the MENA ethosuximide market due to its ability to be combined with other components that can help in the treatment. A capsule can contain ethosuximide along with polyethylene glycol, gelatin, and sorbitol, among other ingredients useful for treating epilepsy. Ethosuximide capsules are capable of suppressing the paroxysmal three cycle per second spike which comes along with lapses of consciousness during absence seizures. Meanwhile, the syrup segment is expected to witness a positive growth in the forecast period, owing to the faster rate of absorption, greater optimisation, easy digestibility, and suitability for children. 

 

Market Share by Procurement

Based on procurement, private procurement (drug stores, private hospitals) segment occupies a growing share of the MENA ethosuximide market due to the rapidly improving private healthcare network in the region. As absence seizures are relatively lesser known and can be difficult to notice and diagnose, potential patients are likelier to belong to higher income groups and visit private hospitals where the quality of treatment is considered to be higher. Although the hospital infrastructure varies significantly between the different countries in the region, efforts to encourage private participation in the healthcare sector, to improve the quality of care while reducing burden on the government, can be witnessed throughout the region. 

 

mena ethosuximide market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

Pfizer Ltd is a leading pharmaceutical company which produces research-based pharmaceutical and biopharmaceutical products. It is also one of the leading manufacturers of vaccines, catering to the treatment demands of various chronic conditions, by innovating to develop new products and formulations. The company was established in the year 1952 and is headquartered in Tadworth, United Kingdom.

 

Essential Pharma Ltd produces and ensures sustainable supply of low-volume clinically-superior, and well established pharmaceutical products. The company strives to help patients get access to good quality therapeutics and medicines that can help them manage their healthcare concerns. The company was founded in the year 2011 and is currently headquartered in Surrey, United Kingdom.  

 

Qatar Pharmaceuticals Industries is a pharmaceutical company which manufactures and sells generic and branded drugs aimed towards improving the health of patients suffering from chronic conditions. The product portfolio of this company includes softgels, liquids, tablets, and capsules, among others. Qatar Pharmaceuticals Industries was founded in 2008 and is headquartered in Doha, Qatar. 

 

Other market players include Delta Pharma, among others.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Procurement
  • Region
Breakup by Product
  • Capsule
  • Tablet
  • Syrup
  • Others
Breakup by Procurement
  • Annual Procurement (Government Agencies, Public Hospitals)
  • Private Procurement (Drug Stores, Private Hospitals)
Breakup by Region
  • Saudi Arabia
  • United Arab Emirates
  • Iran
  • Egypt
  • Morocco
  • Qatar
  • Kuwait
  • Oman
  • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Pfizer Ltd
  • Essential Pharma Ltd
  • Qatar Pharmaceuticals Industries
  • Delta Pharma
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers    
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
7    Opportunities and Challenges in the Market
8    MENA Ethosuximide Market Analysis

    8.1    Key Industry Highlights
    8.2    MENA Ethosuximide Historical Market (2018-2023) 
    8.3    MENA Ethosuximide Market Forecast (2024-2032)
9    MENA Ethosuximide Market by Product
    9.1    Capsule
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2023)
        9.1.3    Forecast Trend (2024-2032)
    9.2    Tablet
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2023)
        9.2.3    Forecast Trend (2024-2032)
    9.3    Syrup
        9.3.1    Market Share
        9.3.2    Historical Trend (2018-2023)
        9.3.3    Forecast Trend (2024-2032)
    9.4    Others
10    MENA Ethosuximide Market by Procurement
    10.1    Annual Procurement (Government Agencies, Public Hospitals)
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2023)
        10.1.3    Forecast Trend (2024-2032)
    10.2    Private Procurement (Drug Stores, Private Hospitals)
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2023)
        10.2.3    Forecast Trend (2024-2032)
11    MENA Ethosuximide Market Share by Country
    11.1    Saudi Arabia
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2023) 
        11.1.3    Forecast Trend (2024-2032)
    11.2    United Arab Emirates
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2023) 
        11.2.3    Forecast Trend (2024-2032)
    11.3    Iran
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2023) 
        11.3.3    Forecast Trend (2024-2032)
    11.4    Egypt
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2023) 
        11.4.3    Forecast Trend (2024-2032)
    11.5    Morocco
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2023) 
        11.5.3    Forecast Trend (2024-2032)
    11.6    Qatar
        11.6.1    Market Share
        11.6.2    Historical Trend (2018-2023) 
        11.6.3    Forecast Trend (2024-2032)
    11.7    Kuwait
        11.7.1    Market Share
        11.7.2    Historical Trend (2018-2023) 
        11.7.3    Forecast Trend (2024-2032)
    11.8    Oman
        11.8.1    Market Share
        11.8.2    Historical Trend (2018-2023) 
        11.8.3    Forecast Trend (2024-2032)
    11.9    Others
12    Market Dynamics
    12.1    SWOT Analysis
        12.1.1    Strengths
        12.1.2    Weaknesses
        12.1.3    Opportunities
        12.1.4    Threats
    12.2    Porter’s Five Forces Analysis
        12.2.1    Supplier’s Power
        12.2.2    Buyer’s Power
        12.2.3    Threat of New Entrants
        12.2.4    Degree of Rivalry
        12.2.5    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Company Profiles
        14.2.1    Pfizer Ltd
            14.2.1.1    Company Overview
            14.2.1.2    Product Portfolio
            14.2.1.3    Demographic Reach and Achievements
            14.2.1.4    Certifications
        14.2.2    Essential Pharma Ltd
            14.2.2.1    Company Overview
            14.2.2.2    Product Portfolio
            14.2.2.3    Demographic Reach and Achievements
            14.2.2.4    Certifications
        14.2.3    Qatar Pharmaceuticals Industries
            14.2.3.1    Company Overview
            14.2.3.2    Product Portfolio
            14.2.3.3    Demographic Reach and Achievements
            14.2.3.4    Certifications
        14.2.4    Delta Pharma
            14.2.4.1    Company Overview
            14.2.4.2    Product Portfolio
            14.2.4.3    Demographic Reach and Achievements
            14.2.4.4    Certifications
        14.2.5    Others
15    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    MENA Ethosuximide Market: Key Industry Highlights, 2018 and 2032
2.    MENA Ethosuximide Historical Market: Breakup by Product (USD Million), 2018-2023
3.    MENA Ethosuximide Market Forecast: Breakup by Product (USD Million), 2024-2032
4.    MENA Ethosuximide Historical Market: Breakup by Procurement (USD Million), 2018-2023
5.    MENA Ethosuximide Market Forecast: Breakup by Procurement (USD Million), 2024-2032
6.    MENA Ethosuximide Historical Market: Breakup by Country (USD Million), 2018-2023
7.    MENA Ethosuximide Market Forecast: Breakup by Country (USD Million), 2024-2032
8.    MENA Ethosuximide Market Structure

Key Questions Answered in the Report

The market is estimated to grow at a CAGR of 3.20% between 2024 and 2032.

The rapid growth of the healthcare sector across the emerging economies of MENA, increasing prevalence of absence seizures in the region, and growing standards of living are the major drivers of the market.

The key trends in the market include the growing research and development activities aimed at improving the quality of epilepsy medications and increasing incorporation of modern technology in diagnostic and treatment procedures.

Capsule, tablet, and syrup, among others, are the different products in the market.

Annual procurement (government agencies, public hospitals) and private procurement (drug stores, private hospitals) are the various procurements of ethosuximide in the market.

Saudi Arabia, United Arab Emirates, Iran, Egypt, Morocco, Qatar, Kuwait, and Oman, among others, are the different countries in the ethosuximide market in MENA.

Ethosuximide is used for treating absence (petit mal) seizures in patients that have epilepsy.

Potential side effects of ethosuximide can include upset stomach, diarrhoea, loss of appetite, drowsiness, and dizziness.

Pfizer Ltd, Essential Pharma Ltd, Qatar Pharmaceuticals Industries, and Delta Pharma, among others, are the key players of the MENA ethosuximide market, according to the report.

Purchase Full Report

Mini Report

$ 2999     $2599
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 4999     $4599
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 7299     $6599
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 9499     $8599
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER